Sanofi petitions FDA over 'misleading' label for rival flu vaccine that failed to confirm benefit
Sanofi is calling on the FDA to change the labels for CSL Limited subsidiary Seqirus’ flu vaccines, which won accelerated approvals but have failed to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
